Nifty
Sensex
:
:
12987.00
44259.74
128.60 (1.00%)
431.64 (0.98%)

Pharmaceuticals & Drugs

Rating :
64/99  (View)

BSE: 540679 | NSE: SMSLIFE

582.15
-2.45 (-0.42%)
26-Nov-2020 | 3:50PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  599.00
  •  599.00
  •  580.00
  •  584.60
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  2565
  •  14.93
  •  712.40
  •  152.65

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 176.97
  • 25.17
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 233.02
  • N/A
  • 1.45

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 68.24%
  • 1.83%
  • 28.84%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 1.09%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 6.45

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 12.46

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 12.07

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Net Sales
62
76
-19%
55
92
-40%
46
107
-57%
47
103
-55%
Expenses
54
68
-21%
48
82
-41%
42
100
-58%
44
91
-52%
EBITDA
8
8
-5%
6
10
-37%
4
7
-51%
3
12
-78%
EBIDTM
13%
11%
12%
11%
8%
7%
6%
12%
Other Income
0
1
-66%
0
0
11%
1
2
-48%
0
0
154%
Interest
1
1
-7%
1
1
-16%
1
1
-15%
1
2
-45%
Depreciation
2
2
1%
2
2
2%
2
2
26%
2
2
16%
PBT
5
6
-15%
4
7
-50%
1
6
-79%
0
9
-
Tax
2
2
-24%
1
2
-54%
0
1
-
0
3
-93%
PAT
3
4
-10%
2
5
-47%
2
5
-66%
0
6
-
PATM
5%
5%
5%
5%
3%
4%
-1%
6%
EPS
11.05
12.27
-10%
8.28
15.72
-47%
5.24
15.34
-66%
-1.13
18.91
-

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 20
Mar 19
Net Sales
209
261
378
Net Sales Growth
-45%
-31%
 
Cost Of Goods Sold
110
158
256
Gross Profit
99
103
122
GP Margin
47%
39%
32%
Total Expenditure
188
235
343
Power & Fuel Cost
-
20
26
% Of Sales
-
8%
7%
Employee Cost
-
27
23
% Of Sales
-
10%
6%
Manufacturing Exp.
-
20
25
% Of Sales
-
8%
7%
General & Admin Exp.
-
6
6
% Of Sales
-
2%
2%
Selling & Distn. Exp.
-
4
7
% Of Sales
-
2%
2%
Miscellaneous Exp.
-
0
1
% Of Sales
-
0%
0%
EBITDA
21
25
35
EBITDA Margin
10%
10%
9%
Other Income
2
2
3
Interest
5
5
6
Depreciation
8
8
6
PBT
10
15
25
Tax
3
4
8
Tax Rate
28%
31%
30%
PAT
7
10
18
PAT before Minority Interest
7
10
18
Minority Interest
0
0
0
PAT Margin
3%
4%
5%
PAT Growth
-62%
-43%
 
EPS
23.40
33.93
59.50

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 20
Mar 19
Shareholder's Funds
116
106
Share Capital
3
3
Total Reserves
113
103
Non-Current Liabilities
50
39
Secured Loans
32
22
Unsecured Loans
5
5
Long Term Provisions
3
2
Current Liabilities
90
132
Trade Payables
49
98
Other Current Liabilities
16
14
Short Term Borrowings
21
13
Short Term Provisions
5
7
Total Liabilities
256
276
Net Block
124
117
Gross Block
150
136
Accumulated Depreciation
25
18
Non Current Assets
146
128
Capital Work in Progress
16
3
Non Current Investment
0
1
Long Term Loans & Adv.
6
5
Other Non Current Assets
0
1
Current Assets
110
149
Current Investments
0
0
Inventories
64
81
Sundry Debtors
22
41
Cash & Bank
8
3
Other Current Assets
17
11
Short Term Loans & Adv.
11
13
Net Current Assets
20
17
Total Assets
256
276

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 20
Mar 19
Cash From Operating Activity
15
30
PBT
15
25
Adjustment
11
9
Changes in Working Capital
-8
2
Cash after chg. in Working capital
18
37
Interest Paid
0
0
Tax Paid
-3
-7
Other Direct Exp. Paid
0
0
Extra & Other Items
0
0
Cash From Investing Activity
-27
-44
Net Fixed Assets
-15
Net Investments
1
Others
-13
Cash from Financing Activity
12
15
Net Cash Inflow / Outflow
0
1
Opening Cash & Equivalents
2
1
Closing Cash & Equivalent
2
2

Financial Ratios

Standalone /

Consolidated
Description
Mar 20
Mar 19
Book Value (Rs.)
383
352
ROA
4%
6%
ROE
9%
17%
ROCE
12%
20%
Fixed Asset Turnover
2.04
3.07
Receivable days
40
36
Inventory Days
91
71
Payable days
116
99
Cash Conversion Cycle
15
8
Total Debt/Equity
0.55
0.44
Interest Cover
4
6

News Update


  • SMS Lifesciences reports 10% fall in Q2 consolidated net profit
    17th Nov 2020, 10:59 AM

    Total income of the company decreased by 19.62% at Rs 62.04 crore for Q2FY21

    Read More
  • SMS Lifesciences reports 47% fall in Q1 consolidated net profit
    24th Aug 2020, 09:54 AM

    Total consolidated income of the company decreased by 40.24% at Rs 55.05 crore for Q1FY21

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.